Arena Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five

Arena Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five

Arena Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five of $700.00 thousand as of 2013-12-31, per its 10-K filed 2014-03-03.

Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive · last filed 2014-03-03

• 2013-12-31: Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five $700.00K.